Security key
00430H201
Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDXQ)
CUSIP: 00430H201
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 100
- Total 13F value
- $1
- Share change
- -4,105,659
- SEC-reported price per share
- $0.01
- Number of holders
- 1
- Value change
- -$2,875,618
- Number of sells
- 39
- Shares outstanding
- 25,187,879
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
1
Top holders
1
AXDXQ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Accelerate Diagnostics, Inc SEC filings
Accelerate Diagnostics, Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00430H201
Recent filing periods:
Ownership snapshot
Top reported holders of AXDXQ - Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Indaba Capital Management...
Disclosed value leader
Indaba Capital Management...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Indaba Capital Management, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Indaba Capital Management, L.P. leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Indaba Capital Management, L.P.'s linked filing trail.
Comparable ownership
Top 5
Indaba Capital Management, L.P.
9.9%
ARMISTICE CAPITAL, LLC
7.4%
GRIFFIN ASSET MANAGEMENT, INC.
4%
VANGUARD GROUP INC
1.9%
Birchview Capital, LP
1.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Indaba Capital Management, L.P. |
13D/G
|
9.9%
|
$2,146,374
2,751,762 shares
|
$0 | 04 Feb 2025 |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
7.4%
from 13D/G
|
$1,317,338
1,879,227 shares
|
— | 31 Mar 2025 |
| GRIFFIN ASSET MANAGEMENT, INC. |
13F
13D/G
Company · Griffin Asset Management, LLC
|
4%
from 13D/G
|
$597,978
853,036 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
1.9%
|
$335,143
478,093 shares
|
— | 31 Mar 2025 |
| Birchview Capital, LP |
13F
Company
|
1.2%
|
$227,992
325,239 shares
|
— | 31 Mar 2025 |
| Lido Advisors, LLC |
13F
Company
|
0.65%
|
$114,376
163,161 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
100
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q3 2025 Across Filers
Q3 2025 holders
0
Q2 2025 holders
1
Holder diff
1
| Investor | Q3 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend